Recruiting

Observational Study

Sponsor:

Foundation Fighting Blindness

Code:

NCT02435940

Conditions

Eye Diseases Hereditary

Retinal Disease

Achromatopsia

Bardet-Biedl Syndrome

Bassen-Kornzweig Syndrome

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The My Retina TrackerĀ® Registry is sponsored by the Foundation Fighting Blindness and is for people affected by one of the rare inherited retinal degenerative diseases studied by the Foundation. It is a patient-initiated registry accessible via a secure on-line portal at www.MyRetinaTracker.org. Affected individuals who register are guided to create a profile that captures their perspective on their retinal disease and its progress; family history; genetic testing results; preventive measures; general health and interest in participation in research studies. The participants may also choose to ask their clinician to add clinical measurements and results at each clinical visit. Participants are urged to update the information regularly to create longitudinal records of their disease, from their own perspective, and their clinical progress. The overall goals of the Registry are: to better understand the diversity within the inherited retinal degenerative diseases; to understand the prevalence of the different diseases and gene variants; to assist in the establishment of genotype-phenotype relationships; to help understand the natural history of the diseases; to help accelerate research and development of clinical trials for treatments; and to provide a tool to investigators that can assist with recruitment for research studies and clinical trials.

Conditions

Eye Diseases Hereditary

Retinal Disease

Achromatopsia

Bardet-Biedl Syndrome

Bassen-Kornzweig Syndrome

Study ID

NCT02435940

Start date

Jun, 2014

Status verified date

May, 2026

Completion date

Jun, 2037

Anticipated

Primary completion date

Jun, 2037

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Diagnosed with an inherited retinal degenerative disease OR

Exclusion Criteria:

  • Glaucoma only
  • Diabetic retinopathy only
  • Non-retinal disease
  • Not heritable retinal disease

Study Design

Enrollment

20000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Number of Participants with Rare Diagnoses Within the Inherited Retinal Degenerative Disease Category as Defined by Clinical Evaluation [ Time Frame: Data collection is ongoing, up to 20 years. ]

Central Contacts and Locations

Central contacts

Locations

Foundation Fighting Blindness

Recruiting

Columbia, Maryland, United States, 21045

Contacts

Principal Investigator:

Todd Durham, PhD

More Information

Sponsor

Foundation Fighting Blindness

Last update posted

May 19, 2026

Last verified

May, 2026

Keywords

  • inherited retinal degenerative disease
  • retinitis pigmentosa
  • Usher
  • Leber
  • Bardet-Biedl
  • Batten
  • Best
  • cone dystrophy
  • cone-rod dystrophy
  • choroideremia
  • congenital night blindness
  • enhanced s-cone
  • cone monochromacy
  • Goldmann-Favre
  • Kearns-Sayre
  • Refsum
  • retinoschisis
  • rod-cone dystrophy
  • rod dystrophy
  • rod monochromacy
  • Sorsby pseudoinflammatory dystrophy
  • stargardt
  • achromatopsia
  • juvenile inherited macular degeneration
  • cone dichromacy
  • cone trichromacy
  • Charcot-Marie-Tooth
  • albipunctate dystrophy

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Foundation Fighting Blindness on 2026-05-19.